TARSONS Share Price Performance
₹181.63
-184.22 (-50.35%)
68.2% undervalued intrinsic discount
₹571.40
Fair Value
Price ₹181.63
AnalystConsensusTarget ₹571.40
AnalystHighTarget ₹760.00
AnalystLowTarget ₹347.00
Fair Value₹612.50
Share Pricen/a
Tarsons Products Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
TARSONS Community Narratives
AN
Fair Value ₹612.5 70.3% undervalued intrinsic discount
Capacity Expansion In Cell Culture And Bioprocessing Will Unlock Markets
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
Fair Value ₹760 76.1% undervalued intrinsic discount
Rising Global Healthcare Spending And Automation Will Expand Lab Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value ₹347 47.7% undervalued intrinsic discount
Rising Sustainability Pressures And Tariffs Will Crush Profitability
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Rising Sustainability Pressures And Tariffs Will Crush Profitability
Key Takeaways Mounting global regulation, anti-plastic sentiment, and shifting technology trends are eroding demand for core plastic products and compressing profit margins. Slow innovation and industry consolidation are increasing Tarsons' vulnerability to margin pressures, competitive threats, and lost access to premium markets.Read more
17
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
₹347
47.7% undervalued intrinsic discount
Fair Value
Revenue
15.06% p.a.
Profit Margin
18.31%
Future PE
22.53x
Price in 2028
₹509.08
Rising Global Healthcare Spending And Automation Will Expand Lab Markets
Key Takeaways Upgraded production, automation, and international expansion strategies position the company for outsized gains in operating leverage, margins, and market share across high-value geographies. Structural global healthcare trends and advanced product offerings are set to drive sustained demand, long-term recurring growth, and superior profitability.Read more
21
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹760
76.1% undervalued intrinsic discount
Fair Value
Revenue
15.41% p.a.
Profit Margin
19.06%
Future PE
48.13x
Price in 2028
₹1.13k
Capacity Expansion In Cell Culture And Bioprocessing Will Unlock Markets
Key Takeaways Capacity expansion and automation position Tarsons for significant market growth, product diversification, and improved margin stability. Global R&D trends and strategic international partnerships support sustained demand and geographic diversification, boosting revenue potential.Read more
62
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
₹612.5
70.3% undervalued intrinsic discount
Fair Value
Revenue
15.22% p.a.
Profit Margin
21.78%
Future PE
34.03x
Price in 2028
₹906.62
Trending Discussion
Recently Updated Narratives
AN
Rising Sustainability Pressures And Tariffs Will Crush Profitability
Fair Value: ₹347 47.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Global Healthcare Spending And Automation Will Expand Lab Markets
Fair Value: ₹760 76.1% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Capacity Expansion In Cell Culture And Bioprocessing Will Unlock Markets
Fair Value: ₹612.5 70.3% undervalued intrinsic discount
10 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Tarsons Products Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
- 3.82
- 65.13%
- 4.91%
- 63.2%
About TARSONS
- Founded
- 1983
- Employees
- 906
- CEO
- WebsiteView website
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables. It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.
